在患有COVID-19住院的患者中,尼古丁胺胺氨酸二核酸代谢的失调

Rodrigo J Valderrábano1, Benjamin Wipper1, Karol Mateusz Pencina1

  • 1Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Aging cell
|October 2, 2024
PubMed
概括

COVID-19患者的血液中尼古丁胺胺二核酸 (NAD+) 略有降低,但NAD+周转率显著增加. 增加的NAD+代谢物,如1-甲基尼古丁胺和特定的代谢物与严重的结果相关,这表明NAD+增加可能有助于治疗COVID-19.